Basic Information
Basic information for SOX2-OT-295-49aa
Peptide Name SOX2-OT-295-49aa
Genome Position chr3:181741183-181741329[+]
Species Human
Peptide Sequence MHCSHCCQLLTKKEKKKKEIKKAVSAPNVKFCSLKDLYIIIVFFFFGKQ
Peptide Length 49
Unique No (SOX2-OT-207-49aa,SOX2-OT-218-49aa,SOX2-OT-225-49aa,SOX2-OT-234-49aa,SOX2-OT-268-49aa,SOX2-OT-276-49aa,SOX2-OT-283-49aa,SOX2-OT-285-49aa-2,SOX2-OT-287-49aa,SOX2-OT-291-49aa,SOX2-OT-292-49aa,SOX2-OT-293-49aa,SOX2-OT-294-49aa,SOX2-OT-296-49aa,SOX2-OT-297-49aa,SOX2-OT-298-49aa,SOX2-OT-299-49aa,SOX2-OT-303-49aa-2,SOX2-OT-304-49aa)
Grand Average of Hydropathicity -0.0286
Relative Molecular Mass 6614.8
Experimental Evidences 1:ribo
lncRNA ID/Name ENSG00000242808;SOX2-OT
Transcript ID/Name ENST00000660576;SOX2-OT-295
Transcript Length 4101
Coding Ability 0.3285
DNA Sequence Corresponding to Peptide ATGCATTGTTCACATTGTTGCCAGCTATTGACCAAAAAAGAGAAGAAGAAAAAAGAAATAAAAAAAGCAGTATCTGCTCCAAACGTCAAGTTTTGCAGTTTGAAAGACTTGTACATTATAATTGTTTTTTTCTTTTTTGGAAAGCAG
Experimental Evidences
   Occupancy of Ribosomes
Tissue :    
Expression type:    Count RPKM
Conservation
   Conservation
Peptide-MHC I binding
   Peptide-MHC I binding
Peptide-MHC II binding
   Peptide-MHC II binding
Spatial Expression
   Spatial Expression
Source :   
Clinical Relevance
   Clinical Relevance
Source :   
Cancer :